Patents by Inventor Alessandra De Lazzari

Alessandra De Lazzari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions comprising safinamide
    Patent number: 11103457
    Abstract: The present invention relates to pharmaceutical compositions comprising safinamide and, more particularly, to taste-masked particles comprising said active ingredient or pharmaceutically acceptable salts thereof, oral dosage forms that include said particles and a process for preparing them.
    Type: Grant
    Filed: October 30, 2018
    Date of Patent: August 31, 2021
    Assignee: Zambon S.P.A.
    Inventors: Alberto Moretto, Alessandra De Lazzari, Fabiana Mazzara
  • Pharmaceutical Solid Compositions Containing Ibuprofen Salts
    Publication number: 20210030705
    Abstract: A pharmaceutical, non-effervescent, solid composition comprising a mixture of a pharmaceutically effective amount of a ibuprofen salt and a pharmaceutically acceptable strong base in a molar ratio of from 1:0.01 to 1:0.8, said composition being such that, when dissolved in drinkable water for dilution, imparts a pH value ranging from 9 to 9.5 to the obtained solution, which do not cause sensory irritation to the oral cavity especially to the back of the mouth and throat, when swallowed.
    Type: Application
    Filed: October 19, 2020
    Publication date: February 4, 2021
    Applicant: Zambon S.P.A.
    Inventors: Alberto Moretto, Alessandra De Lazzari, Lucia Dicorato
  • PHARMACEUTICAL COMPOSITIONS COMPRISING SAFINAMIDE
    Publication number: 20200315969
    Abstract: The present invention relates to pharmaceutical compositions comprising safinamide and, more particularly, to taste-masked particles comprising said active ingredient or pharmaceutically acceptable salts thereof, oral dosage forms that include said particles and a process for preparing them.
    Type: Application
    Filed: October 30, 2018
    Publication date: October 8, 2020
    Applicant: Zambon S.P.A.
    Inventors: Alberto Moretto, Alessandra De Lazzari, Fabiana Mazzara
  • Pharmaceutical compositions comprising safinamide
    Patent number: 10792257
    Abstract: The present invention relates to pharmaceutical compositions comprising safinamide, and, more particularly, to taste-masked particles comprising said active ingredient or pharmaceutically acceptable salts thereof, oral dosage forms that include said particles and a process for preparing them.
    Type: Grant
    Filed: May 30, 2017
    Date of Patent: October 6, 2020
    Assignee: Zambon S.P.A.
    Inventors: Alberto Moretto, Alessandra De Lazzari, Deborah Teoli
  • PHARMACEUTICAL COMPOSITIONS COMPRISING SAFINAMIDE
    Publication number: 20200085769
    Abstract: The present invention relates to pharmaceutical compositions comprising safinamide, and, more particularly, to taste-masked particles comprising said active ingredient or pharmaceutically acceptable salts thereof, oral dosage forms that include said particles and a process for preparing them.
    Type: Application
    Filed: May 30, 2017
    Publication date: March 19, 2020
    Applicant: Zambon S.P.A.
    Inventors: Alberto Moretto, Alessandra De Lazzari, Deborah Teoli
  • Swallowable N-acetylcysteine tablets
    Patent number: 9808427
    Abstract: This invention relates to swallowable tablets containing at least 80% by weight of N-acetylcysteine (NAC) and at least one pharmaceutically acceptable excipient, in particular tablets in which the sulfurous odor is absent, characterized in that the said tablets are assembled using a granulate prepared by means of a process of dry granulating the active ingredient alone, with which the excipients are mixed before compression.
    Type: Grant
    Filed: May 27, 2014
    Date of Patent: November 7, 2017
    Assignee: ZAMBON S.P.A.
    Inventors: Alessandra De Lazzari, Alberto Moretto
  • SWALLOWABLE N-ACETYLCYSTEINE TABLETS
    Publication number: 20160113876
    Abstract: This invention relates to swallowable tablets containing at least 80% by weight of N-acetylcysteine (NAC) and at least one pharmaceutically acceptable excipient, in particular tablets in which the sulfurous odor is absent, characterized in that the said tablets are assembled using a granulate prepared by means of a process of dry granulating the active ingredient alone, with which the excipients are mixed before compression.
    Type: Application
    Filed: May 27, 2014
    Publication date: April 28, 2016
    Inventors: Alessandra De Lazzari, Alberto Moretto
  • Pharmaceutical Solid Compositions Containing Ibuprofen Salts
    Publication number: 20140303250
    Abstract: A pharmaceutical, non-effervescent, solid composition comprising a mixture of a pharmaceutically effective amount of a ibuprofen salt and a pharmaceutically acceptable strong base in a molar ratio of from 1:0.01 to 1:0.8, said composition being such that, when dissolved in drinkable water for dilution, imparts a pH value ranging from 9 to 9.5 to the obtained solution, which do not cause sensory irritation to the oral cavity especially to the back of the mouth and throat, when swallowed.
    Type: Application
    Filed: November 14, 2012
    Publication date: October 9, 2014
    Inventors: Alberto Moretto, Alessandra De Lazzari, Lucia Dicorato
  • Pharmaceutical Composition Comprising Gabapentin
    Publication number: 20080058420
    Abstract: The present invention relates to pharmaceutical compositions comprising gabapentin and a mixture of excipients capable of not promoting the conversion of gabapentin into the corresponding lactamic impurity, processes for their preparation and capsules that contain said compositions.
    Type: Application
    Filed: July 19, 2005
    Publication date: March 6, 2008
    Applicant: ZAMBON GROUP S.P.A.
    Inventors: Luca Rampoldi, Alessandra De Lazzari, Alessandro Grassano